Current Challenges of R/R MM Management and Innovation Updates

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Current Challenges of R/R MM Management and Innovation Updates

Current Challenges of R/R MM Management and Innovation Updates

Playback speed

10 seconds

Experts Discuss the Bispecific Antibody Talquetamab in Patients With R/R MM

By MyCancerHaven FEATURING Ravi Vij, Gurbakhash Kaur

227 views

July 10, 2023

Click here to learn more about MyCancerHaven: https://www.mycancerhaven.org/

0 Comments

Current Challenges of R/R MM Management and Innovation Updates

07:05

ASH 2022 Conference Coverage

ASH 2022 Phase 1/2 Results From MonumenTAL-1: Talquetamab, a G Prote…

Feat. A. Chari

25:36

MyCancerHaven

Experts Discuss the Bispecific Antibody Talquetamab in Patients With…

Feat. R. Vij, G. Kaur

17:42

Abdullah Khan

Treatment Approach in Patients With R/R MM Who Have Failed at Least …

41:23

Cleveland Clinic Taussig Cancer Institute

Understanding Resistance in R/R MM: Mechanisms, Current Practice, an…

Feat. F. Anwer

20:11

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Combination Therapy Trials in Myeloma - A …

Feat. A. Jakubowiak

03:33

ecancer

ASCO® 2023 Insights: "TRIMM-2 Study Summary - Update on Talquet…

Feat. B. Dholaria

05:20

ecancer

ASCO® 2023 Insights: "RedirecTT-1 Study Summary - Teclistamab +…

Feat. Y. C. Cohen

52:39

Yale Cancer Center

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Feat. A. Chari

09:10

University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in Multiple Myeloma (Updates in the …

Feat. D. Sherbenou

32:03

Indy Hematology Review

Emerging and Current Treatment of MM: What Should We Know and What S…

Feat. K. Anderson

54:12

Dana-Farber Cancer Institute

Symptom Management in Multiple Myeloma

Feat. S. Midha

44:49

Dana-Farber Cancer Institute

Recent Updates in Multiple Myeloma

Feat. K. Anderson

27:10

Yale Cancer Center

Highlights in R/R Myeloma and AL Amyloidosis From ASH 2022

Feat. S. Browning

19:18

Total Health

Updates to Management of Patients With Multiple Myeloma

Feat. S. Kumar

41:46

Yale Cancer Center

Early Detection and Interception in Myeloma: The PROMISE Study

Feat. I. Ghobrial

17:32

Current Challenges in Hematology

Patient Journey for a Transplant-Ineligible Patient With MM From 1L …

Feat. R. Mina

15:32

ASH 2022 Conference Coverage

Novel Approaches to Myeloma Burden Assessment

Feat. T. Kourelis

06:16

ASH 2022 Conference Coverage

U.S. Myeloma CAR-T Consortium Real World Experience: Factors Associa…

Feat. H. Hashmi

14:16

ASH 2022 Conference Coverage

Assessing Disease Risk in Multiple Myeloma: High or Low?

Feat. T. Schmidt

12:43

Oliver Van Oekelen